BIOMAT Database Logo BIOMAT Database Logo

Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). 2014

R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

This study was designed to identify genes whose expression in peripheral blood may serve as early markers for treatment response to lithium (Li) in patients with bipolar disorder. Although changes in peripheral blood gene-expression may not relate directly to mood symptoms, differences in treatment response at the biochemical level may underlie some of the heterogeneity in clinical response to Li. Subjects were randomized to treatment with (n=28) or without (n=32) Li. Peripheral blood gene-expression was measured before and 1 month after treatment initiation, and treatment response was assessed after 6 months. In subjects treated with Li, 62 genes were differentially regulated in treatment responders and non-responders. Of these, BCL2L1 showed the greatest difference between Li responders and non-responders. These changes were specific to Li responders (n=9), and were not seen in Li non-responders or patients treated without Li, suggesting that they may have specific roles in treatment response to Li.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D051020 bcl-X Protein A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS and is a regulatory subunit for PROTEIN PHOSPHATASE 1. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL. bcl-XL Protein,bcl-XS Protein,bcl-X(L) Protein,bcl-X(S) Protein,bcl-Xa Protein,bcl-Xalpha Protein,bcl-Xb Protein,bcl-Xbeta Protein,bcl-Xlong Protein,bcl-Xshort Protein,bcl-x(beta) Protein,bcl2-Like 1 Protein,bcl2L1 Protein,bcl X Protein,bcl XL Protein,bcl XS Protein,bcl Xa Protein,bcl Xalpha Protein,bcl Xb Protein,bcl Xbeta Protein,bcl Xlong Protein,bcl Xshort Protein,bcl2 Like 1 Protein

Related Publications

R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
December 2009, Clinical trials (London, England),
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
January 2013, The American journal of psychiatry,
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.
February 2012, Clinical trials (London, England),
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders.
April 2021, Scientific reports,
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.
October 2018, Vaccine,
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Differences in change in coping styles between good responders, moderate responders and non-responders to pulmonary rehabilitation.
December 2015, Respiratory medicine,
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Differences in peripheral blood mononuclear cell gene expression and triglyceride composition in lipoprotein subclasses in plasma triglyceride responders and non-responders to omega-3 supplementation.
January 2019, Genes & nutrition,
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders.
May 2017, Psychiatry research,
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
Peripheral blood mononuclear cell gene expression profile in obese boys who followed a moderate energy-restricted diet: differences between high and low responders at baseline and after the intervention.
January 2015, The British journal of nutrition,
R D Beech, and J J Leffert, and A Lin, and L G Sylvia, and S Umlauf, and S Mane, and H Zhao, and C Bowden, and J R Calabrese, and E S Friedman, and T A Ketter, and D V Iosifescu, and N A Reilly-Harrington, and M Ostacher, and M E Thase, and A Nierenberg
White matter connectivity differences between treatment responders and non-responders in patients with panic disorder.
January 2020, Journal of affective disorders,
Copied contents to your clipboard!